214 related articles for article (PubMed ID: 10913511)
21. A review of the pharmacological and clinical profile of mirtazapine.
Anttila SA; Leinonen EV
CNS Drug Rev; 2001; 7(3):249-64. PubMed ID: 11607047
[TBL] [Abstract][Full Text] [Related]
22. Mirtazapine: a newer antidepressant.
Hartmann PM
Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581
[TBL] [Abstract][Full Text] [Related]
23. Effect of mirtazapine versus fluoxetine on "sleep quality".
Lawrence RW
J Clin Psychiatry; 2004 Aug; 65(8):1149-50. PubMed ID: 15323610
[No Abstract] [Full Text] [Related]
24. Mirtazapine may be useful in treating nausea and insomnia of cancer chemotherapy.
Kast RE
Support Care Cancer; 2001 Sep; 9(6):469-70. PubMed ID: 11585276
[TBL] [Abstract][Full Text] [Related]
25. Depressed in-patients respond differently to imipramine and mirtazapine.
Bruijn JA; Moleman P; Mulder PG; van den Broek WW
Pharmacopsychiatry; 1999 May; 32(3):87-92. PubMed ID: 10463374
[TBL] [Abstract][Full Text] [Related]
26. The pharmacologic profile of mirtazapine.
de Boer T
J Clin Psychiatry; 1996; 57 Suppl 4():19-25. PubMed ID: 8636062
[TBL] [Abstract][Full Text] [Related]
27. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
[TBL] [Abstract][Full Text] [Related]
28. Sexual functioning in depressed outpatients taking mirtazapine.
Boyarsky BK; Haque W; Rouleau MR; Hirschfeld RM
Depress Anxiety; 1999; 9(4):175-9. PubMed ID: 10431683
[TBL] [Abstract][Full Text] [Related]
29. Mirtazapine augmentation in the treatment of refractory depression.
Carpenter LL; Jocic Z; Hall JM; Rasmussen SA; Price LH
J Clin Psychiatry; 1999 Jan; 60(1):45-9. PubMed ID: 10074878
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression.
Bech P
Int J Neuropsychopharmacol; 2001 Dec; 4(4):337-45. PubMed ID: 11806859
[TBL] [Abstract][Full Text] [Related]
31. Mirtazapine: clinical overview.
Gorman JM
J Clin Psychiatry; 1999; 60 Suppl 17():9-13; discussion 46-8. PubMed ID: 10446735
[TBL] [Abstract][Full Text] [Related]
32. Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression.
Münchau A; Langosch JM; Gerschlager W; Rothwell JC; Orth M; Trimble MR
J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):527-33. PubMed ID: 15774440
[TBL] [Abstract][Full Text] [Related]
33. Mirtazapine, an antidepressant.
Puzantian T
Am J Health Syst Pharm; 1998 Jan; 55(1):44-9. PubMed ID: 9437474
[TBL] [Abstract][Full Text] [Related]
34. Effect of Mirtazapine Treatment on Serum Levels of Brain-Derived Neurotrophic Factor and Tumor Necrosis Factor-α in Patients of Major Depressive Disorder with Severe Depression.
Gupta R; Gupta K; Tripathi AK; Bhatia MS; Gupta LK
Pharmacology; 2016; 97(3-4):184-8. PubMed ID: 26854819
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptyline.
Kasper S; Zivkov M; Roes KC; Pols AG
Eur Neuropsychopharmacol; 1997 May; 7(2):115-24. PubMed ID: 9169299
[TBL] [Abstract][Full Text] [Related]
36. Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression.
Kang RH; Choi MJ; Paik JW; Hahn SW; Lee MS
Int J Psychiatry Med; 2007; 37(3):315-29. PubMed ID: 18314859
[TBL] [Abstract][Full Text] [Related]
37. Mirtazapine: a review of its use in major depression and other psychiatric disorders.
Croom KF; Perry CM; Plosker GL
CNS Drugs; 2009; 23(5):427-52. PubMed ID: 19453203
[TBL] [Abstract][Full Text] [Related]
38. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
[TBL] [Abstract][Full Text] [Related]
39. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
Koran LM; Gamel NN; Choung HW; Smith EH; Aboujaoude EN
J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of mirtazapine in obstructive sleep apnea syndrome.
Carley DW; Olopade C; Ruigt GS; Radulovacki M
Sleep; 2007 Jan; 30(1):35-41. PubMed ID: 17310863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
